{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:03:19Z","timestamp":1780066999276,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T00:00:00Z","timestamp":1268870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10620-010-1149-x","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T21:57:53Z","timestamp":1268863073000},"page":"3224-3234","source":"Crossref","is-referenced-by-count":50,"title":["Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection Following Liver Transplantation"],"prefix":"10.1007","volume":"55","author":[{"given":"Timothy M.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Northup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus D.","family":"Hagspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Pruett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J. R.","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,18]]},"reference":[{"key":"1149_CR1","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1097\/00007890-200206270-00016","volume":"73","author":"H Andreu","year":"2002","unstructured":"Andreu H, Rimola A, Bruguera M, et al. Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy. Transplantation. 2002;73:1936\u20131943.","journal-title":"Transplantation"},{"issue":"9","key":"1149_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-6135.2004.00397.x","volume":"4","author":"DB Kaufman","year":"2004","unstructured":"Kaufman DB, Shapiro R, Lucey MR, Cherikh WSRTB, Dyke DB. Immunosuppression: practice and trends. Am J Transplant. 2004;4(9):38\u201353.","journal-title":"Am J Transplant"},{"key":"1149_CR3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1600-6135.2005.00833.x","volume":"5","author":"R Shapiro","year":"2005","unstructured":"Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: evolution in practice and trends, 1993\u20132003. Am J Transplant. 2005;5:874\u2013886.","journal-title":"Am J Transplant"},{"key":"1149_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jss.2006.08.025","volume":"138","author":"CB Ramirez","year":"2007","unstructured":"Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18\u00a0months. J Surg Res. 2007;138:198\u2013204.","journal-title":"J Surg Res"},{"key":"1149_CR5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/lt.500050608","volume":"5","author":"AJ Bathgate","year":"1999","unstructured":"Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg. 1999;5:475\u2013479.","journal-title":"Liver Transpl Surg"},{"key":"1149_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archsurg.133.2.167","volume":"133","author":"GA Berlakovich","year":"1998","unstructured":"Berlakovich GA, Rockenschaub S, Taucher S, Kaserer K, Muhlbacher F, Steiniger R. Underlying disease as a predictor for rejection after liver transplantation. Arch Surg. 1998;133:167\u2013172.","journal-title":"Arch Surg"},{"key":"1149_CR7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00007890-199511270-00008","volume":"60","author":"F Conti","year":"1995","unstructured":"Conti F, Dousset B, Archambeau D, Louvel A, Houssin D, Calmus Y. Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients. Transplantation. 1995;60:1104\u20131108.","journal-title":"Transplantation"},{"key":"1149_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.510230207","volume":"23","author":"O Farges","year":"1996","unstructured":"Farges O, Saliba F, Farhamant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology. 1996;23:240\u2013248.","journal-title":"Hepatology"},{"key":"1149_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/lt.500010104","volume":"1","author":"LR Fisher","year":"1995","unstructured":"Fisher LR, Henley KS, Lucey MR. Acute cellular rejection after liver transplantation: variability, morbidity, and mortality. Liver Transpl Surg. 1995;1:10\u201315.","journal-title":"Liver Transpl Surg"},{"key":"1149_CR10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(05)60138-9","volume":"349","author":"DF Mirza","year":"1997","unstructured":"Mirza DF, Gunson BK, Soonawalla Z, et al. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. Lancet. 1997;349:701\u2013702.","journal-title":"Lancet"},{"key":"1149_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004230050201","volume":"384","author":"CA Seiler","year":"1999","unstructured":"Seiler CA, Dufour JF, Renner EL, et al. Primary liver disease as a determinant for acute rejection after liver transplantation. Langenbecks Arch Surg. 1999;384:259\u2013263.","journal-title":"Langenbecks Arch Surg"},{"key":"1149_CR12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.510280306","volume":"28","author":"RH Wiesner","year":"1998","unstructured":"Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology. 1998;28:638\u2013645.","journal-title":"Hepatology"},{"key":"1149_CR13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.tp.0000266678.32250.76","volume":"83","author":"N Assy","year":"2007","unstructured":"Assy N, Adams PC, Myers P, et al. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation. 2007;83:1571\u20131576.","journal-title":"Transplantation"},{"key":"1149_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TP.0000164349.54297.95","volume":"80","author":"N Ruvo De","year":"2005","unstructured":"De Ruvo N, Cucchetti A, Lauro A, et al. Preliminary results of a \u201cprope\u201d tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. Transplantation. 2005;80:8\u201312.","journal-title":"Transplantation"},{"key":"1149_CR15","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2005.03.081","volume":"37","author":"M Bahra","year":"2005","unstructured":"Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. Transplant Proc. 2005;37:1700\u20131702.","journal-title":"Transplant Proc"},{"key":"1149_CR16","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3748\/wjg.14.4849","volume":"14","author":"RR Razonable","year":"2008","unstructured":"Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol. 2008;14:4849\u20134860.","journal-title":"World J Gastroenterol"},{"key":"1149_CR17","first-page":"1453","volume":"92","author":"HR Rosen","year":"1997","unstructured":"Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol. 1997;92:1453\u20131457.","journal-title":"Am J Gastroenterol"},{"key":"1149_CR18","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.transproceed.2005.03.030","volume":"37","author":"ML Fernandes","year":"2005","unstructured":"Fernandes ML, Lee YM, Sutedja D, et al. Treatment of steroid-resistant acute liver transplant rejection with basiliximab. Transplant Proc. 2005;37:2179\u20132180.","journal-title":"Transplant Proc"},{"key":"1149_CR19","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.transproceed.2005.10.022","volume":"37","author":"DW Orr","year":"2005","unstructured":"Orr DW, Portmann BC, Knisely AS, et al. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation. Transplant Proc. 2005;37:4373\u20134379.","journal-title":"Transplant Proc"},{"key":"1149_CR20","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0041-1345(00)02556-2","volume":"33","author":"JD Eason","year":"2001","unstructured":"Eason JD, Blazek J, Mason A, Nair S, Loss GE. Steroid-free immunosuppression through thymoglobulin induction in liver transplantation. Transplant Proc. 2001;33:1470\u20131471.","journal-title":"Transplant Proc"},{"key":"1149_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jlts.2001.26353","volume":"7","author":"JD Eason","year":"2001","unstructured":"Eason JD, Loss GE, Blazek J, Nair S, Mason AL. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl. 2001;7:693\u2013697.","journal-title":"Liver Transpl"},{"key":"1149_CR22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.TP.0000062834.30922.FE","volume":"75","author":"JD Eason","year":"2003","unstructured":"Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation. 2003;75:1396\u20131399.","journal-title":"Transplantation"},{"key":"1149_CR23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.tp.0000282914.20578.7b","volume":"84","author":"T Kato","year":"2007","unstructured":"Kato T, Gaynor JJ, Yoshida H, et al. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. Transplantation. 2007;84:829\u2013835.","journal-title":"Transplantation"},{"key":"1149_CR24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/lt.21185","volume":"13","author":"T Soliman","year":"2007","unstructured":"Soliman T, Hetz H, Burghuber C, et al. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transpl. 2007;13:1039\u20131044.","journal-title":"Liver Transpl"},{"key":"1149_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2007.00463.x","volume":"20","author":"T Soliman","year":"2007","unstructured":"Soliman T, Hetz H, Burghuber C, et al. Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation. Transpl Int. 2007;20:447\u2013452.","journal-title":"Transpl Int"},{"key":"1149_CR26","first-page":"570","volume":"9","author":"CG Bijleveld","year":"1996","unstructured":"Bijleveld CG, Klompmaker IJ, van den Berg AP, et al. Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation. Transpl Int. 1996;9:570\u2013575.","journal-title":"Transpl Int"},{"key":"1149_CR27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/00007890-200211150-00016","volume":"74","author":"AJ Demetris","year":"2002","unstructured":"Demetris AJ, Ruppert K, Dvorchik I, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002;74:1290\u20131296.","journal-title":"Transplantation"},{"key":"1149_CR28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","volume":"31","author":"A Demetris","year":"2000","unstructured":"Demetris A, Adams D, Bellamy C, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology. 2000;31:792\u2013799.","journal-title":"Hepatology"},{"key":"1149_CR29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-199801000-00004","volume":"22","author":"AJ Demetris","year":"1998","unstructured":"Demetris AJ, Seaberg EC, Batts KP, et al. Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database. Am J Surg Pathol. 1998;22:28\u201339.","journal-title":"Am J Surg Pathol"},{"key":"1149_CR30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","volume":"19","author":"KP Batts","year":"1995","unstructured":"Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409\u20131417.","journal-title":"Am J Surg Pathol"},{"key":"1149_CR31","first-page":"2693","volume":"25","author":"P De","year":"1993","unstructured":"De P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? Transplant Proc. 1993;25:2693\u20132694.","journal-title":"Transplant Proc"},{"key":"1149_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-200001270-00019","volume":"69","author":"R Hirose","year":"2000","unstructured":"Hirose R, Roberts JP, Quan D, et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000;69:307\u2013311.","journal-title":"Transplantation"},{"key":"1149_CR33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.TP.0000101738.27552.9D","volume":"77","author":"UP Neumann","year":"2004","unstructured":"Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation. 2004;77:226\u2013231.","journal-title":"Transplantation"},{"key":"1149_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(98)80224-9","volume":"28","author":"M Berenguer","year":"1998","unstructured":"Berenguer M, Prieto M, Cordoba J, et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol. 1998;28:756\u2013763.","journal-title":"J Hepatol"},{"key":"1149_CR35","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/lt.20944","volume":"12","author":"JR Burton Jr","year":"2006","unstructured":"Burton JR Jr, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl. 2006;12:S38\u2013S47.","journal-title":"Liver Transpl"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1149-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1149-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1149-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:56Z","timestamp":1559245376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1149-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,18]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1149-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,18]]}}}